SIRT3-SOD2-ROS pathway is involved in linalool-induced glioma cell apoptotic death

Yanhao Cheng1, Chao Dai1, Jian Zhang1

  • 1Department of Functional Neurosurgery, The People's Hospital of Linyi, Linyi 276003, Shandong, China.

Insights

Linalool, a natural compound, effectively inhibits glioma cell growth by inducing apoptosis. It achieves this by regulating the SIRT3-SOD2-ROS signaling pathway, offering a potential new avenue for brain tumor treatment.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Glioma is the most common primary brain tumor in adults.
  • Chemotherapy for glioma faces challenges due to drug resistance.
  • Linalool is a monoterpene alcohol with diverse pharmacological properties.

Purpose of the Study:

  • To investigate the anti-glioma effects of linalool.
  • To elucidate the molecular mechanisms underlying linalool's action on glioma cells.

Main Methods:

  • Cell viability assays (MTT) were performed on U87-MG glioma cells.
  • Apoptosis was assessed using TUNEL staining and Western blot analysis of apoptosis-related proteins (Bax, Bak, Bcl-2, Bcl-xl, Caspase 3, Caspase 9).
  • Mitochondrial function, SOD activity, SIRT3 and SOD2 expression, acetylation, and protein interactions were analyzed.

Main Results:

  • Linalool significantly reduced glioma cell viability and induced apoptosis in a dose- and time-dependent manner.
  • Linalool altered mitochondrial function, increased pro-apoptotic markers, and decreased anti-apoptotic markers.
  • Linalool modulated the SIRT3-SOD2-ROS pathway, decreasing SIRT3 expression and SOD2-SIRT3 interaction, which was linked to increased ROS and apoptosis.

Conclusions:

  • Linalool exhibits significant anti-glioma activity by promoting apoptosis.
  • The mechanism involves the regulation of the SIRT3-SOD2-ROS signaling pathway.
  • Linalool represents a potential therapeutic agent for glioma treatment.